Back

Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters

European Heart Journal

28 May 2024
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes Interventional Cardiology

Contributors

Diana A Gorog
Diana A Gorog

Author

National Heart and Lung Institute Imperial College London , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Thromboelastography-based assessment of thrombus burden in STEMI
20 March 2026
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019
thumbnail
Congress Presentation
Platelet reactivity and activated clotting time predict haemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources